BEIJING, Nov. 4, 2015 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical", or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced it will release its financial results for the third quarter of 2015 after the U.S. market closes on November 18, 2015.
Management will hold a conference call to discuss the results at 8:00 a.m. Eastern Time on November 19, 2015 (9:00 p.m.Beijing/Hong Kong time on November 19, 2015).
The dial-in details for the live conference call are as follows:
|
U.S. Toll Free:
|
1 866 519 4004
|
|
International:
|
65 67135090
|
|
U.K. Toll Free:
|
08082346646
|
|
Hong Kong Toll Free:
|
800906601
|
|
China Local:
|
400-620-8038/800-819-0121
|
|
Passcode:
|
CCM
|
A replay of the conference call may be accessed by phone at the following numbers from 11:00 a.m. Eastern TimeNovember 19, 2015 to 11:59 p.m. Eastern TimeNovember 27, 2015:
|
U.S. Toll Free:
|
1 855 452 5696
|
|
International:
|
61 2 8199 0299
|
|
Conference ID:
|
74380959
|
Additionally, a live and archived webcast of the conference call will be available on the investor relations section of the Company's website at: http://ir.concordmedical.com/
About Concord Medical
Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of June 30, 2015, the Company operated a network of 129 centers with 76 hospital partners that spanned 53 cities and 25 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. As part of its high-end cancer hospital development strategy and oversea business extension, the Company acquired Fortis Surgical Hospital, a private hospital in Singapore in April, 2015. For more information, please see http://ir.concordmedical.com.
For more information, please contact:
Mr. Adam J. Sun (Chinese and English)
+86 10 5957 5266
adam.sun@concordmedical.com
Ms. Fang Liu (Chinese and English)
+86 10 5903 6688 (ext. 639)
fang.liu@concordmedical.com
ICR Inc.
Mr. William Zima
+1-203-682-8233
William.Zima@icrinc.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/concord-medical-to-report-third-quarter-2015-financial-results-300172028.html
SOURCE Concord Medical Services Holdings Limited
